Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Intravenous Lacosamide Compared With Fosphenytoin in the Treatment of Patients With Frequent Nonconvulsive Seizures

ClinicalTrials.gov ID: NCT01458522

Public ClinicalTrials.gov record NCT01458522. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 1:28 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Utility of Intravenous Lacosamide Compared With Fosphenytoin in the Treatment of Patients With Frequent Nonconvulsive Seizures

Study identification

NCT ID
NCT01458522
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Aatif Husain
Other
Enrollment
74 participants

Conditions and interventions

Interventions

  • fPHT Drug
  • LCM Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2012
Primary completion
Jun 30, 2014
Completion
Jun 30, 2015
Last update posted
Jun 10, 2018

2012 – 2015

United States locations

U.S. sites
11
U.S. states
8
U.S. cities
9
Facility City State ZIP Site status
Huntington Memorial Hospital Pasadena California 91109
Yale University School of Medicine New Haven Connecticut 06520
Emory University School of Medicine Atlanta Georgia 30307
Massachusetts General Hospital Boston Massachusetts 02214
Beth Israel Deaconess Medical Center Boston Massachusetts 02215
Brigham and Woman's Hospital Boston Massachusetts 02215
Mission Hospital Asheville North Carolina 28801
Duke University Medical Center Durham North Carolina 27710
Medical University of South Carolina Charleston South Carolina 29425
Vanderbilt University Medical Center Nashville Tennessee 37232
University of Texas Southwestern Medical Center Dallas Dallas Texas 75390-8589

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01458522, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 10, 2018 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01458522 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →